FOXO4-DRI is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
FOXO4-DRI (FOXO4 D-Retro-Inverso peptide) is a Senolytic peptide researched for senescent cell elimination, improved tissue function, cartilage regeneration, testosterone restoration, anti-aging. For beginners, start at the lower end of the dosage range (5-10 mg per dose) and administer 3 consecutive days per cycle via subcutaneous or intravenous injection.
What Is FOXO4-DRI?
FOXO4-DRI (FOXO4 D-Retro-Inverso peptide) is a Senolytic peptide. Synthetic peptide designed to disrupt FOXO4-p53 protein-protein interaction in senescent cells, with D-retro-inverso modification for protease resistance.
It is researched for its potential effects on senescent cell elimination, improved tissue function, cartilage regeneration, testosterone restoration, anti-aging. The only peptide specifically designed to eliminate senescent cells — a fundamentally different intervention than any other peptide, which typically replace or stimulate endogenous molecules. This is targeted cellular demolition.
For beginners: This guide assumes no prior peptide experience. We'll cover everything from what FOXO4-DRI is to how to reconstitute, inject, and structure your first cycle.
How Does FOXO4-DRI Work?
Competes with endogenous FOXO4 for p53 binding, disrupting their interaction and causing p53 to translocate to mitochondria. This triggers intrinsic apoptotic cell death specifically in senescent (aged, dysfunctional) cells while sparing healthy cells. The D-retro-inverso modification provides protease resistance and enhanced cellular penetration.
Understanding the mechanism helps set realistic expectations about what FOXO4-DRI can and cannot do.
How Do You Get Started With FOXO4-DRI?
Step 1 — Source: Purchase FOXO4-DRI from a vendor with third-party Certificate of Analysis (COA) testing. This confirms purity (aim for 98%+) and rules out contamination.
Step 2 — Supplies: You'll need bacteriostatic water, insulin syringes (1mL/100-unit), alcohol swabs, and a clean workspace.
Step 3 — Reconstitute: Add BAC water to the FOXO4-DRI vial — use our peptide calculator for exact amounts. Let the water run down the side of the vial; never spray directly on the powder. Swirl gently.
Step 4 — Dose: Draw 5-10 mg per dose using the calculator's syringe unit conversion.
Step 5 — Inject: Clean the injection site with alcohol. Pinch a fold of abdominal fat and insert the needle at 45° for subcutaneous injection. Push the plunger slowly and hold for 5 seconds.
Calculate Your FOXO4-DRI Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for FOXO4-DRI.
Open Calculator →What Should Your First FOXO4-DRI Cycle Look Like?
Dosage: Start at the lower end of 5-10 mg per dose. This lets you assess tolerance before committing to a full cycle.
Frequency: 3 consecutive days per cycle via subcutaneous or intravenous injection.
Duration: 3-day dosing periods, repeated every 4-6 weeks for 16 weeks total. Don't cut cycles short — many Senolytic peptide effects take weeks to fully manifest.
Off-cycle: Plan a 4-week break before starting another cycle.
What Side Effects Should Beginners Watch For?
Minimal side effects in preclinical studies. Potential transient inflammation during senescent cell clearance as cellular debris triggers immune response. No human safety data published.
As a beginner, track everything — dose, time, injection site, and any effects (positive or negative). This data helps optimize future cycles.
What Are Common Beginner Mistakes?
Not using BAC water: Sterile water lacks the preservative that prevents bacterial growth. Always use bacteriostatic water.
Inconsistent dosing: Skipping doses or varying timing significantly reduces outcomes. Set a daily alarm.
Poor storage: Reconstituted FOXO4-DRI must stay refrigerated at 2-8°C. Leaving it at room temperature degrades the compound rapidly.
Buying cheap: Low-cost peptides without COA testing may be underdosed, contaminated, or mislabeled. Quality matters more than price.
Bottom Line for FOXO4-DRI Beginners
Start at the lower end of 5-10 mg per dose, dose 3 consecutive days per cycle, cycle for 3-day dosing periods, repeated every 4-6 weeks for 16 weeks total, and track everything. Source from COA-tested vendors and follow proper reconstitution protocol.
Read our complete peptide beginner's guide for general peptide education beyond FOXO4-DRI.
Complete Guide
FOXO4-DRI : Benefits, Dosage, Side Effects & Research
Related Reading
- FOXO4-DRI Dosage Guide
- FOXO4-DRI Benefits
- FOXO4-DRI Side Effects
- FOXO4-DRI Stacking Guide
- FOXO4-DRI Cycle Guide
- FOXO4-DRI Research
Research-Grade Sourcing
If you're going to research FOXO4-DRI, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is FOXO4-DRI?
FOXO4-DRI (FOXO4 D-Retro-Inverso peptide) is a Senolytic peptide. Synthetic peptide designed to disrupt FOXO4-p53 protein-protein interaction in senescent cells, with D-retro-inverso modification for protease resistance. It is researched for senescent cell elimination, improved tissue function, cartilage regeneration, testosterone restoration, anti-aging.
What is the recommended FOXO4-DRI dosage?
Common dosages: 5-10 mg per dose administered 3 consecutive days per cycle via subcutaneous or intravenous injection. Cycle length: 3-day dosing periods, repeated every 4-6 weeks for 16 weeks total. Half-life: prolonged by D-retro-inverso modification; specific human half-life not published. Use our peptide calculator for exact reconstitution math.
What are the side effects of FOXO4-DRI?
Minimal side effects in preclinical studies. Potential transient inflammation during senescent cell clearance as cellular debris triggers immune response. No human safety data published.
Is FOXO4-DRI safe?
FOXO4-DRI has shown a preliminary safety profile in research. Not FDA-approved. Research use only. All research should follow appropriate safety protocols.